예측 종양학 Inc.
이 기호는 더 이상 활성화되지 않습니다.

SecurityPOAI / Predictive Oncology Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership12,631 shares
Latest Disclosed Value $ 20,462
UBS Group AG reports 384.88% increase in ownership of POAI / Predictive Oncology Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 12,631 shares of Predictive Oncology Inc. (US:POAI) valued at $20,462 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 2,605 shares of Predictive Oncology Inc.. This represents a change in shares of 384.88% during the quarter. The current value of the position is $75,154 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F AXE COMPUTE COM NEW 74039M408 12,631 10,026 384.88 20 11.11 0.0000
2026-01-29 2025-12-31 13F AXE COMPUTE COM NEW 74039M408 2,605 2,484 2,052.89 19 1,700.00 0.0000
2025-11-13 2025-09-30 13F PREDICTIVE ONCOLOGY COM NEW 74039M408 121 121 2 0.0000
2023-05-12 2023-03-31 13F PREDICTIVE ONCOLOGY COM NEW 74039M200 23,922 22,101 1,213.67 8 0.0000
2023-02-08 2022-12-31 13F PREDICTIVE ONCOLOGY COM NEW 74039M200 1,821 -14,222 -88.65 1 -100.00 0.0000
2022-11-10 2022-09-30 13F PREDICTIVE ONCOLOGY COM NEW 74039M200 16,043 15,488 2,790.63 6 0.0000
2022-08-10 2022-06-30 13F PREDICTIVE ONCOLOGY COM NEW 74039M200 555 555 0 0.0000
2022-05-16 2022-03-31 13F PREDICTIVE ONCOLOGY COM NEW 74039M200 0 -36,666 -100.00 0 -100.00
2022-02-14 2021-12-31 13F PREDICTIVE ONCOLOGY COM NEW 74039M200 36,666 17,878 95.16 35 40.00 0.0000
2021-11-15 2021-09-30 13F PREDICTIVE ONCOLOGY COM NEW 74039M200 18,788 15,113 411.24 25 400.00 0.0000
2021-08-13 2021-06-30 13F PREDICTIVE ONCOLOGY COM NEW 74039M200 3,675 3,675 5 0.0000
2021-05-12 2021-03-31 13F PREDICTIVE ONCOLOGY COM NEW 74039M200 0 -37,386 -100.00 0 -100.00
2021-02-11 2020-12-31 13F PREDICTIVE ONCOLOGY COM NEW 74039M200 37,386 34,665 1,273.98 27 1,250.00 0.0000
2020-11-12 2020-09-30 13F PREDICTIVE ONCOLOGY COM NEW 74039M200 2,721 -1,440 -34.61 2 -71.43 0.0000
2020-07-31 2020-06-30 13F PREDICTIVE ONCOLOGY COM NEW 74039M200 4,161 -1,829 -30.53 7 -22.22 0.0000
2020-05-01 2020-03-31 13F PREDICTIVE ONCOLOGY COM NEW 74039M200 5,990 3,969 196.39 9 80.00 0.0000
2020-02-14 2019-12-31 13F PREDICTIVE ONCOLOGY COM NEW 74039M200 2,021 2,021 -66.26 5 -44.44 0.0000
2019-05-14 2019-03-31 13F PRECISION THERAPEUTICS COM 74033P100 0 -53 -100.00 0 -100.00 0.0000
2019-02-14 2018-12-31 13F PRECISION THERAPEUTICS COM 74033P100 53 53 0 0.0000
2018-05-15 2018-03-31 13F SKYLINE MED COM PAR 83084T606 0 -8,031 -100.00 0 -100.00
2018-02-14 2017-12-31 13F SKYLINE MED COM PAR 83084T606 8,031 2,966 58.56 8 14.29 0.0000
2017-11-14 2017-09-30 13F SKYLINE MED COM PAR 83084T606 5,065 -599 -10.58 7 -12.50 0.0000
2017-11-14 2017-06-30 13F/A-1 SKYLINE MED COM PAR 83084T606 5,664 5,664 11.83 8 14.29 0.0000
2017-08-14 2017-06-30 13F SKYLINE MED COM PAR 83084T606 5,664 5,664 8
2017-11-14 2017-03-31 13F/A-1 SKYLINE MED COM PAR 83084T606 0 -2,642 -100.00 0 -100.00
2017-02-14 2016-12-31 13F SKYLINE MED COM PAR 83084T606 2,642 -20,151 -88.41 7 75.00 0.0000
2016-11-14 2016-09-30 13F SKYLINE MED COM NEW 83084T309 22,793 22,793 762.72 4 -42.86 0.0000
2016-08-12 2016-06-30 13F SKYLINE MED COM NEW 83084T309 0 -11,865 -100.00 0 -100.00
2016-05-12 2016-03-31 13F SKYLINE MED COM NEW 83084T309 11,865 10,219 620.84 2 -60.00 0.0000
2016-02-16 2015-12-31 13F SKYLINE MED COM NEW 83084T309 1,646 893 118.59 5 150.00 0.0000
2016-02-16 2015-12-31 13F SKYLINE MED UNIT 99/99/9999 83084T408 2,031 931 14 0.0000
2015-11-13 2015-09-30 13F SKYLINE MED COM NEW 83084T309 753 753 2 0.0000
2015-11-13 2015-09-30 13F SKYLINE MED UNIT 99/99/9999 83084T408 1,100 1,100 8 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.